Tag Archives: USPTO

PTO Rules on Pre-issuance Submissions by Third Parties

Posted on July 20, 2012 by Warren Woessner

On July 17th, the USPTO released the rules that will govern the mandate in Section 8 of the AIA that requires the Office to provide for the submission by third parties of patents, published patent applications and other materials that … Continue reading →

Posted in Patent Reform Legislation, USPTO Practice and Policy | Tagged , , , , , , , | 1 Comment

“In Leukemia Treatment, Glimpses of the Future” of Medicine and IP

Posted on July 9, 2012 by Warren Woessner

A provocative article in the Sunday New York Times recounted how a young cancer researcher, who was diagnosed with acute lymphoblastic leukemia (ALL), and who responded but relapsed twice after receiving chemotherapy and bone marrow transplant, achieved a third remission … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment

PTO Guidelines for Process Claims Involving Laws of Nature

Posted on July 8, 2012 by Warren Woessner

On July 3rd, the PTO released 13 pages entitled “2012 Interim Procedure for Subject Matter Eligibility Analysis of Process Claims Involving Laws of Nature.” They are intended as guidance for Examiners who encounter such claims, e.g., in Group 1600, in … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , | 1 Comment

Will Universities Benefit from their Micro Entity Applicants?

Posted on June 11, 2012 by Warren Woessner

In an introductory post on the USPTO’s proposed rules: “Changes to Implement Micro Entity Status for Paying Patent Fees,” 77 Fed. Reg. 31806 (May 30 2010), my partner, Gary Speier, spent some time on new 35 USC 123(a), which defines … Continue reading →

Posted in AIA Patent Reform, Patent Reform Legislation | Tagged , , , , , | 1 Comment